Company page

Citius Oncology, Inc.

Citius Oncology, Inc. (Ticker: CTOR) is a public company based in the United States, focused on developing innovative cancer therapies. With a market capitalization of approximately $64 million, Citius is dedicated to advancing treatments that aim to improve patient outcomes in oncology. The company is actively engaged in research and development to bring new solutions to the market.